memantine and HIV
memantine has been researched along with HIV in 2 studies
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Schifitto, G | 1 |
| Yiannoutsos, CT | 1 |
| Simpson, DM | 1 |
| Marra, CM | 1 |
| Singer, EJ | 1 |
| Kolson, DL | 1 |
| Nath, A | 1 |
| Berger, JR | 1 |
| Navia, B | 1 |
| Kornhuber, J | 1 |
| Bormann, J | 1 |
Trials
1 trial available for memantine and HIV
| Article | Year |
|---|---|
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy.
Topics: Adult; Excitatory Amino Acid Antagonists; Female; HIV; HIV Infections; Humans; Male; Memantine; Peri | 2006 |
Other Studies
1 other study available for memantine and HIV
| Article | Year |
|---|---|
Neuroprotective effects of memantine.
Topics: Animals; Dizocilpine Maleate; HIV; HIV Envelope Protein gp120; Memantine; N-Methylaspartate; Neurons | 1993 |